Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 269

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Use of a gonadotropin‐releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

Open access
Somers, Emily C., Marder, Wendy, Christman, Gregory M., Ognenovski, Vladimir, McCune, W. Joseph · 2005 · Arthritis & Rheumatism

Abstract

Objective: Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study was performed to evaluate the effectiveness of depot leuprolide acetate, a synthetic gonadotropin‐releasing hormone analog (GnRH‐a), for protection against POF during CYC therapy. Methods: Young women with severe SLE treated in a standardized protocol of monthly intravenous bolus CYC were offered treatment with GnRH‐a (depot leuprolide acetate; a 3.75‐mg monthly injection during the standard CYC regimen). Patients treated with GnRH‐a were compared with controls individually matched by age (±5 years) and by cumulative CYC dose (±5 gm). Reproductive status was determined after a minimum followup of 3 years after CYC therapy. The primary outcome was time to POF. Paired summary statistical analyses, Kaplan‐Meier survival estimates, and Cox regression analyses were performed to assess differences in outcome between groups. Results: POF developed in 1 of 20 women treated with GnRH‐a (5%) compared with 6 of 20 controls (30%) matched by age and cumulative CYC dose (matched odds ratio 0.09, P < 0.05). Kaplan‐Meier estimates demonstrated improved cumulative ovarian protection over time in the GnRH‐a–treated group (P = 0.04). Conclusion: Treatment with GnRH‐a during CYC therapy was associated with a significant reduction of POF in young women with severe SLE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.21263

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 269

Metadata

Authors
Somers, E. C., Marder, W., Christman, G. M., Ognenovski, V., & McCune, W. J.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2005-09
Volume
52
Issue
9
Pages
2761-2767
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2019229100
Cited by
269
References
33
FWCI
17.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.